Involvement of Autophagy in Levodopa‐Induced Dyskinesia
Open Access
- 18 January 2021
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 36 (5) , 1137-1146
Abstract
Background: Autophagy is intensively studied in cancer, metabolic and neurodegenerative diseases, but little is known about its role in pathological conditions linked to altered neurotransmission. We examined the involvement of autophagy in levodopa (l‐dopa)‐induced dyskinesia, a frequent motor complication developed in response to standard dopamine replacement therapy in parkinsonian patients.Methods: We used mouse and non‐human primate models of Parkinson's disease to examine changes in autophagy associated with chronic l‐dopa administration and to establish a causative link between impaired autophagy and dyskinesia.Results: We found that l‐dopa‐induced dyskinesia is associated with accumulation of the autophagy‐specific substrate p62, a marker of autophagy deficiency. Increased p62 was observed in a subset of projection neurons located in the striatum and depended on l‐dopa‐mediated activation of dopamine D1 receptors, and mammalian target of rapamycin. Inhibition of mammalian target of rapamycin complex 1 with rapamycin counteracted the impairment of autophagy produced by l‐dopa, and reduced dyskinesia. The anti‐dyskinetic effect of rapamycin was lost when autophagy was constitutively suppressed in D1 receptor‐expressing striatal neurons, through inactivation of the autophagy‐related gene protein 7.Conclusions: These findings indicate that augmented responsiveness at D1 receptors leads to dysregulated autophagy, and results in the emergence of l‐dopa‐induced dyskinesia. They further suggest the enhancement of autophagy as a therapeutic strategy against dyskinesia. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder SocietyKeywords
Funding Information
- Hjärnfonden
- Magnus Bergvalls Stiftelse
- National Institute of Neurological Disorders and Stroke (R01 NS095435)
- National Institute on Drug Abuse (R01 DA07418)
- Parkinsonfonden
- Simons Foundation
- Vetenskapsrådet (2015‐02886)
This publication has 51 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesiaNature Neuroscience, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for AutophagyJournal of Biological Chemistry, 2009
- Molecular mechanisms of mTOR-mediated translational controlNature Reviews Molecular Cell Biology, 2009
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy MachineryMolecular Biology of the Cell, 2009
- Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for AutophagyMolecular Biology of the Cell, 2009
- A Translational Profiling Approach for the Molecular Characterization of CNS Cell TypesCell, 2008
- Impairment of starvation-induced and constitutive autophagy in Atg7-deficient miceJournal of Cell Biology, 2005
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979